This nationwide descriptive analysis provides a comprehensive snapshot of real-world survival after RC for MIBC in Japan. This nationwide data reveal marked heterogeneity in patient characteristics, treatment patterns, and outcomes, and provide a foundation for identifying clinically relevant hypotheses for future risk-adjusted analyses.
Hatakeyama et al. (Wed,) studied this question.